A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma
Clinical trial NCT00246012 · COMPLETED
Trial details
- NCT number
- NCT00246012
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-06-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.